MedTech company

we provide a method to reduce the risk of preterm birth related to fetoscopic interventions.

Born to deliverOur Mission

The project resulted from a combined doctoral study from the Ecole Polytechnique Federale de Lausanne (EPFL) and UniversitätsSpital Zürich (USZ). KOVE is the sum of years of research towards enabling surgeons to have a secure way to perform pre-natal treatment, which suffers from a high risk of preterm birth after the surgery. This side-effect is seen to be the greatest limitation for the progress of fetal therapy.


Understand, Create, Save

We save babies that are now doomed to death. We give surgeons a reliable tool to work with. We avoid huge expenses in neonatal care for society.

Meet our Team

Dr. Yannick Devaud

Founder, CEO, Ph.D in Biotechnology
and Bioengineering

Prof. Roland Zimmermann

Advisor in fetal therapy
Obstetric clinic director USZ, IFMSS member

Prof. Nicole Ochsenbein-Kölble

Advisor in fetal therapy
Fetal surgeon USZ, IFMSS member

PD Martin Ehrbar

Scientific Advisor for obstetric tissue
engineering / Obstetric research director USZ


Let’s save lives together